Back

CARotid plaqUe StabilizatiOn and regression with evolocumab: the CARUSO Study

2026-03-04 cardiovascular medicine Title + abstract only
View on medRxiv
Show abstract

BackgroundEvolocumab promotes coronary plaque regression in patients with coronary artery disease, but little is known regarding carotid plaques (CP). This study aimed to evaluate the impact of evolocumab on top of lipid-lowering therapy (ELLT) on carotid morphological stabilization (MS) and plaque regression (PR) compared to lipid-lowering therapy (LLT) alone. MethodsAsymptomatic patients with internal carotid stenosis[≥]50% and LDL-C[≥]100 mg/dL were randomized to ELLT or LLT and monito...

Predicted journal destinations